Loading
Life sciences · Journal article
International Journal of Pharmaceutical Research and Applications · October 11, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background: Dyslipidemia is a metabolic disorder characterized by abnormalities in lipid profile and is an important risk factor for cardiovascular disease.When obesity is accompanied by metabolic abnormalities such as dyslipidemia and hypertension, it is considered a metabolically unhealthy obesity (MUO) phenotype, which is associated with increased cardiometabolic risk.In Ayurveda, Dyslipidemia bears a close resemblance to Medoroga, a Santarpanajanya Vyadhi characterized by predominant Kaphamedo Dushti. Method: A 42-year-old male patient presented with weight gain, Anga Gourava (heaviness of the body), Ati Kshut Pravrutti (increased appetite), Ati Sweda (excessive sweating), and Alasya (lethargy), along with an altered lipid profile. The presenting complaints were addressed through an Ayurvedic treatment protocol comprising Shodhana and Shamana therapies, along with Pathya Ahara-Vihara.Result: The patient showed improvement in clinical features and a reduction in body weight. The lipid profile exhibited positive results with reductions in serum total cholesterol, LDL, VLDL, and triglyceride levels, along with an increase in serum HDL levels.Conclusion: This case highlights the potential of Ayurveda in the management of dyslipidemia through a holistic and individualized approach, emphasizing restoration of metabolic balance through Shodhana and Shamana therapies rather than merely addressing symptoms.